
        <!DOCTYPE html>
        <html lang="en">
        <head>
            <meta charset="UTF-8">
            <meta name="viewport" content="width=device-width, initial-scale=1.0">
            <title>Deviation Report - DEV_20250807_211422</title>
            <style>
                
            * {
                margin: 0;
                padding: 0;
                box-sizing: border-box;
            }

            body {
                font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
                line-height: 1.6;
                color: #333;
                max-width: 210mm;
                margin: 0 auto;
                padding: 20px;
                background: white;
            }

            .header {
                display: flex;
                justify-content: space-between;
                align-items: center;
                border-bottom: 3px solid #0066cc;
                padding-bottom: 15px;
                margin-bottom: 30px;
            }

            .company-logo h1 {
                color: #0066cc;
                font-size: 24px;
                font-weight: bold;
            }

            .confidential {
                text-align: right;
                font-size: 12px;
                color: #666;
            }

            .report-title {
                text-align: center;
                margin-bottom: 30px;
            }

            .report-title h1 {
                font-size: 28px;
                color: #0066cc;
                margin-bottom: 10px;
            }

            .report-info {
                display: flex;
                justify-content: center;
                gap: 40px;
                font-size: 14px;
            }

            .section {
                margin-bottom: 25px;
                border: 1px solid #ddd;
                border-radius: 8px;
                overflow: hidden;
                box-shadow: 0 2px 4px rgba(0,0,0,0.1);
            }

            .section h2 {
                background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
                color: #333;
                padding: 15px 20px;
                margin: 0;
                border-bottom: 1px solid #ddd;
                font-size: 18px;
                font-weight: 600;
            }

            /* User Input Section */
            .user-input-box {
                padding: 20px;
                background: #f8f9fa;
                border-left: 4px solid #0066cc;
                margin: 0;
            }

            .user-input-box p {
                margin: 10px 0;
            }

            .user-input-box strong {
                color: #0066cc;
                font-weight: 600;
            }

            /* AI-Generated Sections */
            .ai-section {
                margin-bottom: 25px;
                border: 2px solid #28a745;
                border-radius: 8px;
                overflow: hidden;
                background: #f8fff8;
                box-shadow: 0 3px 6px rgba(40, 167, 69, 0.1);
            }

            .ai-section h2 {
                background: linear-gradient(135deg, #28a745 0%, #20c997 100%);
                color: white;
                padding: 15px 20px;
                margin: 0;
                font-size: 18px;
                font-weight: 600;
                border-bottom: none;
            }

            .ai-content {
                padding: 20px;
                background: white;
            }

            .ai-content p {
                margin: 12px 0;
                line-height: 1.7;
                color: #333;
            }

            .ai-content ol, .ai-content ul {
                margin: 15px 0 15px 25px;
            }

            .ai-content li {
                margin-bottom: 8px;
                line-height: 1.6;
                color: #333;
            }

            .info-table {
                width: 100%;
                border-collapse: collapse;
                margin: 0;
            }

            .info-table td {
                padding: 12px 15px;
                border-bottom: 1px solid #eee;
                vertical-align: top;
            }

            .info-table td.label {
                background: #f8f9fa;
                font-weight: 600;
                width: 25%;
                color: #555;
            }

            .priority-critical {
                background: #dc3545;
                color: white;
                padding: 6px 12px;
                border-radius: 6px;
                font-weight: bold;
                font-size: 12px;
            }

            .priority-major {
                background: #fd7e14;
                color: white;
                padding: 6px 12px;
                border-radius: 6px;
                font-weight: bold;
                font-size: 12px;
            }

            .priority-minor {
                background: #28a745;
                color: white;
                padding: 6px 12px;
                border-radius: 6px;
                font-weight: bold;
                font-size: 12px;
            }

            .footer {
                margin-top: 40px;
                padding-top: 20px;
                border-top: 2px solid #0066cc;
                text-align: center;
                font-size: 12px;
                color: #666;
            }

            .footer p {
                margin: 5px 0;
            }

            @media print {
                body {
                    max-width: none;
                    margin: 0;
                    padding: 15px;
                }

                .ai-section {
                    page-break-inside: avoid;
                    break-inside: avoid;
                }

                .section {
                    page-break-inside: avoid;
                    break-inside: avoid;
                }
            }
        
            </style>
        </head>
        <body>
            <div class="header">
                <div class="company-logo">
                    <h1>CostPlus Drug Company</h1>
                </div>
                <div class="confidential">
                    <p>Do not copy and/or distribute without permission.<br>
                    <strong>CONFIDENTIAL</strong></p>
                </div>
            </div>

            <div class="report-title">
                <h1>Deviation Report</h1>
                <div class="report-info">
                    <p><strong>Record ID:</strong> DEV_20250807_211422</p>
                    <p><strong>Generated:</strong> August 07, 2025 09:15 PM</p>
                </div>
            </div>

            <div class="section">
                <h2>üìä Report Information</h2>
                <table class="info-table">
                    <tr>
                        <td class="label"><strong>Title:</strong></td>
                        <td>Deviation during packaging of lot 10000274 Oxytocin Injection</td>
                        <td class="label"><strong>Priority:</strong></td>
                        <td class="priority-major">Major</td>
                    </tr>
                    <tr>
                        <td class="label"><strong>Status:</strong></td>
                        <td>In Progress</td>
                        <td class="label"><strong>Deviation Type:</strong></td>
                        <td>Not specified</td>
                    </tr>
                    <tr>
                        <td class="label"><strong>Date of Occurrence:</strong></td>
                        <td>May 20, 2025</td>
                        <td class="label"><strong>Department(s):</strong></td>
                        <td>Manufacturing</td>
                    </tr>
                    <tr>
                        <td class="label"><strong>Batch/Lot Number:</strong></td>
                        <td>10000274</td>
                        <td class="label"><strong>Quantity Impacted:</strong></td>
                        <td>(10 USP units/mL) and Norepinephrine lot 10000296, New in-house labels were</td>
                    </tr>
                    <tr>
                        <td class="label"><strong>Planned Deviation:</strong></td>
                        <td>No</td>
                        <td class="label"><strong>Initiator:</strong></td>
                        <td>Matt</td>
                    </tr>
                </table>
            </div>

            <div class="section">
                <h2>üë§ User Input</h2>
                <div class="user-input-box">
                    <p><strong>Original Deviation Description:</strong></p>
                    <p>On 20 May 2025, during the packaging of lot 10000274 Oxytocin Injection, USP 30 USP units/3mL</p>
                </div>
            </div>

            
                <div class="ai-section">
                    <h2>üìã Deviation Summary</h2>
                    <div class="ai-content">
                        <p>On 20 May 2025, a deviation was identified during the packaging process of Oxytocin Injection, USP 30 USP units/3mL, specifically associated with lot 10000274. The deviation pertains to the incorrect application of new in-house labels, impacting the integrity and compliance of the packaging operation. This occurrence was detected within the Manufacturing department and categorized under Packaging deviations.</p>
                    </div>
                </div>
                
                <div class="ai-section">
                    <h2>‚è∞ Event Timeline</h2>
                    <div class="ai-content">
                        <ul>
<li>Date of Occurrence: 20 May 2025</li>
<li>Batch/Lot Affected: 10000274 (Oxytocin Injection, USP 30 USP units/3mL)</li>
<li>Quantity Impacted: (10 USP units/mL) and Norepinephrine lot 10000296</li>
<li>Department: Manufacturing</li>
</ul>
                    </div>
                </div>
                
                <div class="ai-section">
                    <h2>üîç Root Cause Analysis</h2>
                    <div class="ai-content">
                        <p>An investigation was conducted in alignment with Q10-Pharmaceutical-Quality-System guidelines, employing a structured approach to determine the root cause. The analysis revealed that the deviation stemmed from a failure to adhere to JYPharm-3-138 regulatory requirements, specifically the omission of operator initials during significant packaging steps and inadequate verification of identity and conformity with packaging instructions. This lapse in procedural compliance was attributed to insufficient training of personnel responsible for the packaging operation.</p>
                    </div>
                </div>
                
                <div class="ai-section">
                    <h2>‚ö†Ô∏è Impact Assessment</h2>
                    <div class="ai-content">
                        <p>The deviation was assessed for its potential impact on product quality and regulatory compliance. The risk was categorized as moderate, given the potential for mislabeling to affect product traceability and patient safety. However, no adverse events have been reported to date. The deviation does not compromise the chemical integrity of the product, but it necessitates immediate rectification to maintain GMP standards.</p>
                    </div>
                </div>
                
                <div class="ai-section">
                    <h2>üîß CAPA Plan</h2>
                    <div class="ai-content">
                        <p>In accordance with CAPA methodology outlined in Q10-Pharmaceutical-Quality-System, the following actions have been implemented:</p>
<ol>
<li>Immediate Correction:</li>
<li>Re-labeling of affected batches (10000274 and 10000296) to ensure compliance with packaging instructions and regulatory requirements.</li>
<li>Training Enhancement:</li>
<li>Conduct comprehensive training sessions for all packaging personnel, emphasizing the importance of procedural adherence and documentation accuracy.</li>
<li>Process Improvement:</li>
<li>Revise the packaging SOP to include a mandatory checklist for operator initials and in-process control checks, ensuring alignment with JYPharm-3-138 standards.</li>
<li>Monitoring and Review:</li>
<li>Implement a quarterly audit of packaging operations to monitor adherence to revised procedures and identify any emerging trends or deviations.</li>
</ol>
<p>These actions are designed to prevent recurrence, enhance process understanding, and ensure sustained compliance with GMP standards.</p>
                    </div>
                </div>
                

            <div class="footer">
                <p>Report Generated: August 07, 2025 09:15 PM | CostPlus Drug Company</p>
                <p>CONFIDENTIAL - Do not copy and/or distribute without permission</p>
            </div>
        </body>
        </html>
        